Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients

Condition:   Chronic Kidney Diseases Intervention:   Drug: impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients Sponsor:   Hospices Civils de Lyon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials